All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Mar 2, 2020
DEA Proposes Rules for Mobile Narcotic Treatment Units
Feb 23, 2020
GAO Says DEA Could Do More to Identify Diversion Using Current Data
Feb 23, 2020
Georgia Pharmacist Owner Accused of Ignoring ‘Red Flags’ for Diversion, Failing to Maintain Records
Feb 8, 2020
DEA Continues to Press for Class-Wide Fentanyl Scheduling as Congress Extends Temporary Authorization
Feb 3, 2020
Newly Approved Migraine Medicine to Schedule V
Feb 2, 2020
National Drug Threats Include Fentanyl, Methamphetamine, Cocaine and Others
Jan 27, 2020
DEA Completes Scheduling Actions for Synthetic Cannabinoids and Zulresso; Removes Opioid Treatment Drug From Control
Jan 25, 2020
DEA Adds 15 Substances to List of Exempt Chemical Mixtures
Jan 20, 2020
Warner Prods DEA to Issue Rule on Telehealth Prescribing
Jan 13, 2020
New Drug Sunosi Placed in Schedule IV
Dec 31, 2019
DEA to Clarify 'Place of Business' for Registrants; Could Revise Rules for Marijuana Growers, MAT and CMEA Compliance in 2020
Dec 24, 2019
Websites Offering THC Vaping Cartridges Shut Down
Dec 23, 2019
Kroger to Pay $225K to Settle Alleged CSA Violations in Virginia
Nov 30, 2019
2020 Production Quotas Finalized With Some Changes to Opioids, Designer Drugs
Nov 11, 2019
USDA Rules for Hemp Cover DEA-Registered Testing Laboratories
Nov 5, 2019
Counterfeit Opioid Pills Could Be Lethal, DEA Warns
Oct 31, 2019
Control of Synthetic Cannabinoid FUB-AMB Continues
Oct 27, 2019
Quota Rules Changing for Schedule I and II Substances, Three List I Chemicals
Oct 20, 2019
Only a Third of Physicians Prescribing Controlled Substances Used EPCS in 2017, Study Finds
Oct 8, 2019
Two-Year Transition Allowed to New Form 222
Oct 7, 2019
Doctor’s Registration Suspended for Two Years Despite Eight-Year Medicare Exclusion
Oct 1, 2019
IG Critiques DEA Response to Opioid Crisis, Recommends Nine Actions
Sep 29, 2019
First 2020 Proposed Quotas Published
Sep 22, 2019
DEA Proposes Control of Chemicals Used in Illicit Fentanyl
Sep 11, 2019
FDA Requests Comment on International Scheduling of Synthetic Cannabinoids, Other Drugs

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.